Plants for delivery of edible vaccines

Current Opinion in Biotechnology

Volumn 11, Issue 2, 2000, Pages 126-129

  Walmsley, Amanda M ^a,b   Arntzen, Charles J ^a  

^a United States Department of Agriculture Agricultural Research Service and Boyce Thompson Institute for Plant Research   (United States)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ESCHERICHIA COLI ENDOTOXIN; HEPATITIS B SURFACE ANTIGEN; VACCINE;

ANTIGEN EXPRESSION; CHIMERA; CLINICAL TRIAL; CROP; DIARRHEA; DISEASE CONTROL; DRUG SAFETY; HEPATITIS B; HIGHER PLANT; HUMAN; IMMUNOLOGY; MOLECULAR BIOLOGY; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION;

ANIMALIA; EMBRYOPHYTA; ESCHERICHIA COLI;

EID: 0034026208     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00070-7     Document Type: Review

References (37)

1. Division of Microbiology and Infectious Diseases: The Jordan Report: Accelerated Development of Vaccines. Bethesda, MD: National Institute of Allergy and Infectious Diseases; 1998.
2. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med. 4:1998;607-609. This landmark paper describes the first human clinical trial of a plant-derived, edible vaccine. Oral delivery of the plant-derived vaccinogen enabled recognition of the vaccinogen by the human immune system and induction of a mucosal immune response.
3. Mason H.S., Lam D.M-K., Arntzen C.J. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA. 89:1992;11745-11749.
4. Ehsani P., Khabiri A., Domansky N.N. Polypeptides of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA. 190:1997;107-111.
5. McGarvey P.B., Hammond J., Dienelt M.M., Hooper D.C., Fu Z.F., Dietzschold B., Kiprowski H., Michaels F.H. Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology. 13:1995;1484-1487.
6. Hein M.B., Yeo T-C., Wang F., Sturtevant A. Expression of cholera toxin subunits in plants. Ann NY Acad Sci. 792:1995;50-56.
7. Arakawa T., Chong D.K.X., Merritt J.L., Langridge W.H.R. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Trans Res. 6:1997;403-413.
8. Tackaberry E.S., Dudani A.K., Prior F., Tocchi M., Sardana R., Altosaar I., Ganz P.R. Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine. 17:1999;3020-3029. The first report of tissue specific expression of a vaccinogen is given by this paper. It was demonstrated that the rice glutelin promoter can direct expression of a vaccinogen from the human cytomegalovirus specifically to the seeds of tobacco.
9. Thanavakam Y., Yang Y-F., Lyons P., Mason H.S., Arntzen C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA. 92:1995;3358-3361.
10. Yusibov V., Koprowski H. Plants as vectors for biomedical products. J Med Food. 1:1998;5-12.
11. Haq T.A., Mason H.S., Clements J.D., Arntzen C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 268:1995;714-716.
12. Mason H.S., Ball J.M., Shi J-J., Jiang X., Estes M.K., Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA. 93:1996;5340-5353.
13. Carillo C., Wigdorovitz A., Oliveros J.C., Zamorano P.I., Sadir A.M., Gomez N., Salinas J., Escribano J.M., Borca M.V. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J Virol. 72:1998;1688-1690.
14. Valenzuelz P., Coit D., Medina-Selby A., Kuo C., van Nest G., Burke R.L., Bull P., Urdea M.S., Graves P.V. Antigen engineering in yeast: synthesis and assembly of hybrid hepatitis B surface antigen-herpes simplex gD particles. Biotechnology. 3:1985;323-326.
15. Adams S.E., Dawson K.M., Gull K., Kingsman S.M., Kingsman A.J. The expression of hybrid HIV-Ty virus-like particles in yeast. Nature. 329:1987;68-70.
16. Clarke B.E., Brown A.L., Grace K.G., Hastings G.Z., Brown F., Rowlands D.J., Francis M.J. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatits B virus core particles produced in bacteria. J Gen Virol. 71:1990;1109-1117.
17. Dedieu J-F., Ronco J., van der Werf S., Hogle J.M., Henin Y., Girard M. Poliovirus chimeras expressing sequences from the principle neuralising domain of human immunodeficiency virus type 1. J Virol. 66:1992;3161-3167.
18. Mastico R.A., Talvot S.J., Stockley P.G. Multiple presentation of foreign peptides on the surface of an RNA-free bacteriophage capsid. J Gen Virol. 74:1993;541-548.
19. Lomonossoff G., Johnson J.E. Eukaryotic viral expression systems for polypeptides. Semin Virol. 6:1995;257-267.
20. Usha R., Rohll J.B., Spall V.E., Shanks M., Maule A.J., Johnson J.E., Lomonossoff G.P. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology. 197:1993;366-374.
21. Porta C., Spall V.E., Loveland J., Johnson J.E., Barker P.J., Lomonossoff G.P. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology. 202:1994;949-955.
22. McLain L., Durrani Z., Wisniewski L.A., Porta C., Lomonossoff G.P., Dimmock N.J. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine. 14:1996;799-810.
23. Porta C., Spall V.E., Lin T., Johnson J.E., Lomonossoff G.P. The development of cowpea mosaic virus as a potential source of novel vaccines. Intervirol. 39:1996;79-84.
24. Joelson T., Akervlom L., Oxelfelt P., Strandberg B., Tomenius K., Morris T.J. Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol. 78:1997;1213-1217.
25. Yusibov V., Modelska A., Steplewski K., Agadjanyan M., Weiner D., Hooper D.G., Koprowski H. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA. 94:1997;5784-5788.
26. Fitchen J., Beachy R.N., Hein M.B. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine. 13:1995;1051-1057.
27. Dalsgaard K., Uttenthal A., Jones T.D., Xu F., Merryweather A., Hamilton W.D.O., Langeveld J.P.M., Boshuizen R.S., Kamstrup S., Lomonossoff G.P.et al. Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol. 15:1997;248-252.
28. Arakawa T., Chong D.K.X., Langridge W.H.R. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol. 16:1998;292-297.
29. Durrani Z., McInerney T.L., McLain L., Jones T., Bellaby T., Brennan F.R., Dimmock N.J. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization. J Immunol Methods. 220:1998;93-103.
30. Brennan F.R., Jones T.D., Gilleland L.B., Bellaby T., Xu F., North P.C., Thompson A., Staczek J., Lin T., Johnson J.E.et al. Pseudomonas aeroginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiol. 145:1999;211-220.
31. Koo M., Bendahmane M., Lettieri G.A., Paoletti A.D., Lane T.E., Fitchen J.H., Buchmeier M.J., Beachy R.N. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci USA. 96:1999;7774-7779.
32. Wigdorovitz A.W., Carrillo C. Dus, Santos, M.J., Trono, K., Peralta, A., Gomez, M.C., Rios, R.D., Franzone, P.M., Sadir, A.M., Escribano, J.M., Borca, M.V. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1 Virology. 255:1999;347-353.
33. Mason H.S., Haq T.A., Clements J.D. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine. 16:1998;1336-1343. The ability of a synthetic gene to increase the stability of mRNA and hence gene expression is demonstrated in this report. After constructing a plant-optimized synthetic gene, transgene expression levels were increased 3-14-fold when compared to wild-type transgene expression.
34. Brennan F.R., Bellaby T., Helliwell S.M., Jones T.D., Kamstrup S., Dalsgaard K., Flock J-I., Hamilton W.D.O. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J Virol. 73:1999;930-938. This paper extensively researches the immune response elicited after mucosal delivery of a plant-derived vaccine. It demonstrates the ability of a nasally administered vaccinogen to induce a mucosal immune response in multiple distant sites without the requirement of an adjuvant.
35. Modelska A., Dietzschold B., Sleysh N., Fu Z.F., Steplewski K., Hooper D.C., Kiprowski H., Yusibov V. Immunization against rabies with a plant-derived antigen. Proc Natl Acad Sci USA. 95:1998;2481-2485. Induction of a significant mucosal immune response after oral immunization with a chimeric plant virus is described for the first time in this paper. Mice fed chimeric virus-infected spinach leaves displayed significant local and systemic immune responses. The immune responses were approximately two times higher than the responses induced by 10 times as much purified chimeric virus delivered through gastric intubation.
36. Tacket C.O., Reid R.H., Boedeker E.C., Losonsky G., Nataro J.P., Bhagat H., Edelman R. Enternal immunisation and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine. 12:1994;1270-1274.
37. Curtiss, R.I., Cardineau, C.A.: Oral immunisation by transgenic plants. World Patent Application 1990, WO 90/02484.